<!DOCTYPE html>
<html lang="en">
<head>
	<meta http-equiv="content-type" content="text/html; charset=utf-8" />
	<title>Final task</title>
	<link rel="stylesheet" type="text/css" href="stylesheets/style.css">
	<script type="text/javascript" src="script.js"></script>
</head>
<body>
	<header>
		<ul>
			<li class="home"><a href=""><img src="assets/images/home.png"></a></li>
			<li><a href="">Graphics</a></li>
			<li><a href="">Calculator</a></li>
			<li><a href="">Competitors</a></li>
		</ul>
	</header>
	<div class="tab active">
		<h1>Xarelto<sup>&#174;</sup>: An Effective Treatment Option in Your VTE Patients width Cancer<sup>a,8</sup></h1>

		<p class="left_text">% PATIENTS<sup>b</sup></p>

		<div class="graphics">
			<div class="vertical_line">
				<ul class="section_line">
					<li>8 -</li>
					<li>7 -</li>
					<li>6 -</li>
					<li>5 -</li>
					<li>4 -</li>
					<li>3 -</li>
					<li>2 -</li>
					<li>1 -</li>
					<li>0</li>
				</ul>
			</div>
			<div class="horizontal_line">
				<p>Cancer</p>
			</div>
		</div>
		<footer>
			<p><sup>a</sup>Xarelto is contraindicated in lesions or conditions, if they are cred to be a significant risk for major bleeding, which may include the presence of malignant neoplasms at high lisk of bleeding.<br>
			<sup>b</sup>Outcome: symptomatic, recurrent VTE.</p>
		</footer>
	</div>

	<div class="tab">
		
	</div>
	
	<div class="tab">
		
	</div>

</body>
</html>